We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
T. Rowe Price
TROW
$23.9B
| $86.6M | 0.11% |
437,280
-15,479
| -3% | -$2.89M |
|
152
IQVIA
IQV
$38.7B
| $86.5M | 0.11% |
357,107
-25,360
| -7% | -$5.86M |
|
153
eBay
EBAY
$50.6B
| $85.6M | 0.11% |
1,218,633
-34,144
| -3% | -$2.14M |
|
|
154
NXP Semiconductors
NXPI
$57.8B
| $85.4M | 0.11% |
415,236
+203,393
| +96% | +$40.8M |
|
155
Kimberly-Clark
KMB
$36.3B
| $84.3M | 0.11% |
630,252
-23,890
| -4% | -$3.19M |
|
|
TWTR
156
DELISTED
Twitter, Inc.
TWTR
| $84.3M | 0.11% |
1,224,923
-37,496
| -3% | -$2.3M |
|
157
Uber
UBER
$143B
| $83.3M | 0.11% |
1,661,950
+156,304
| +10% | +$8.16M |
|
158
EOG Resources
EOG
$79.2B
| $82.6M | 0.11% |
990,210
-10,656
| -1% | -$843K |
|
159
Aon
AON
$76.5B
| $82.6M | 0.11% |
345,766
-22,280
| -6% | -$5.44M |
|
160
Dow Inc
DOW
$21.9B
| $82.1M | 0.11% |
1,297,518
-49,483
| -4% | -$3.27M |
|
161
Newmont
NEM
$98.7B
| $82.1M | 0.11% |
1,295,037
-68,574
| -5% | -$4.6M |
|
162
Johnson Controls International
JCI
$88.8B
| $81.9M | 0.11% |
1,193,319
-9,251
| -0.8% | -$597K |
|
163
Moderna
MRNA
$21.8B
| $81.4M | 0.11% |
346,291
+26,740
| +8% | +$4.78M |
|
164
Vertex Pharmaceuticals
VRTX
$121B
| $80.8M | 0.11% |
400,756
-105,890
| -21% | -$22.1M |
|
165
Amphenol
APH
$198B
| $80.5M | 0.11% |
2,352,896
-80,296
| -3% | -$2.71M |
|
166
KLA
KLAC
$239B
| $79.3M | 0.1% |
2,445,860
-195,990
| -7% | -$6.28M |
|
167
Allstate
ALL
$68B
| $78.9M | 0.1% |
604,805
-36,344
| -6% | -$4.7M |
|
168
Zoom
ZM
$28.2B
| $77.6M | 0.1% |
200,467
+22,309
| +13% | +$7.43M |
|
|
ALXN
169
DELISTED
Alexion Pharmaceuticals
ALXN
| $77.4M | 0.1% |
421,197
-7,839
| -2% | -$1.35M |
|
170
MetLife
MET
$61.9B
| $76.6M | 0.1% |
1,280,357
-79,650
| -6% | -$5.05M |
|
171
Digital Realty Trust
DLR
$69.7B
| $76.4M | 0.1% |
507,929
-20,085
| -4% | -$3.04M |
|
172
Ross Stores
ROST
$80.5B
| $75.1M | 0.1% |
605,977
-30,533
| -5% | -$3.81M |
|
173
Align Technology
ALGN
$12.1B
| $74.7M | 0.1% |
122,263
-5,964
| -5% | -$3.53M |
|
174
ResMed
RMD
$30.6B
| $74.4M | 0.1% |
301,821
-16,553
| -5% | -$3.48M |
|
175
HCA Healthcare
HCA
$87.2B
| $74.2M | 0.1% |
358,875
-34,380
| -9% | -$7.01M |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.